How new technologies can improve drug safety reporting

18 July 2022
digital_health_safety_reporting_doctors_big

In this week's Expert View, Andrew Donaldson, head of pharmacovigilance and regulatory technology at IQVIA, explains how case collection systems can help improve adverse event intake processes.

Life science companies look to technology solution to increase efficiencies and reduce errors, whether these are related to data entry or other reasons.

In the area of adverse event intake and collection, it is no different. The time has come to take this manual process and add in automated steps to collect, share and analyze data across the organization.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical